s6y
Company name or ticker
Search
Bassler Bonnie L
4
REGENERON PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
Filed
Monday, August 5, 2024
Period
Aug 2, 2024
Accession number
0001883850-24-000041
Documents
PRIMARY DOCUMENT
4
On sec.gov
Filing index
All files
Complete submission text
SGML header